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Abstract
Rules on the reprocessing of medical devices were put into place in
Germanyin2001.Thepresentarticleexplainsthebackgroundsituation
and the provisions that are currently in force.
Kerstin Klosz
1
1 Regulatory Affairs and
Strategic Quality
Theimplementationofthesestatutoryrequirementsisdescribedusing
the example of the quality management system of Germany’s market Management Manager,
leader,VanguardAG.Thisqualitymanagementsystemwassuccessfully Vanguard AG, Berlin,
Germany certified pursuant to DIN EN ISO 13485:2003 for the scope "repro-
cessing of medical devices", including class “critical C”, in accordance
with the recommendation of the Commission for Hospital Hygiene and
the Prevention of Infection at the Robert-Koch-Institute (RKI) and the
German Federal Institute for Drugs and Medical Devices (BfArM) on the
“Hygiene requirements for reprocessing of medical devices”.
Keywords: processing of medical devices, processing requirements,
processing procedure, quality management, risk management,
certification
Zusammenfassung
In Deutschland wurde die Aufbereitung von Medizinprodukten im Jahr
2001 geregelt. In der vorliegenden Arbeit werden die Hintergründe und
die bestehenden Regularien erläutert.
Am Beispiel des Qualitätsmanagementsystems der Vanguard AG als
MarktführerinDeutschlandwirddieUmsetzungdergesetzlichenAnfor-
derungenbeschrieben.ImErgebniskonntedasQualitätsmanagement-
system gemäß DIN EN ISO 13485 für den Geltungsbereich der Aufbe-
reitung von Medizinprodukten, einschließlich der Einstufung „kritisch
C“,entsprechendderEmpfehlungderKommissionfürKrankenhaushy-
gieneundInfektionspräventionbeimRobert-Koch-Institut(RKI)unddes
Bundesinstitutes für Arzneimittel und Medizinprodukte (BfArM) zu den
„Anforderungen an die Hygiene bei der Aufbereitung von Medizinpro-
dukten“ zertifiziert werden.
Schlüsselwörter: Aufbereitung von Medizinprodukten, Anforderungen
an die Aufbereitung von Medizinprodukten, Aufbereitungsverfahren,
Qualitätsmanagement, Risikomanagement, Zertifizierung
Regulatory and normative
requirements, guidelines and
expert recommendations
The fulfilment of the regulatory requirements is a pre-
requisiteforsuccessfulqualitymanagement.Whencerti-
fying the quality management system of a company pro-
cessing medical devices, the certifying body, in addition
to official control and supervision, also checks whether
these requirements have been fulfilled. The processing
of medical devices is also subject to a large number of
provisionsfromvariousfields.Increasinglyinrecentyears,
in addition to safety and hygiene requirements, aspects
of environmental management and, most recently, cost-
effectiveness and increases in efficiency have come into
play. The bibliography contained in this paper does not
claim to be complete, as there may also be additional
requirements when using special processing techniques
orwheretherearespecialenvironmentalconditions.The
GermanOrdinanceontheInstallation,OperationandUse
of Medical Devices (MPBetreibV) plays a central role in
the configuration, operation and use of medical devices.
The ordinance sets out the legal requirements for pro-
cessing medical devices.
Section 4 MPBetreibV “Maintenance” states:
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or facilities with the requisite specialist knowledge,
the requirements and the necessary means to prop-
erly carry out this task to perform the maintenance
(service,inspection,repairandprocessing)ofmedical
devices.
2. The processing of medical devices intended to be
appliedsterileorsemi-sterileistobecarriedout,while
observing the manufacturer’s instructions, using ap-
propriate validated procedures in order to guarantee
that the success of these procedures is verifiably en-
sured, and the safety and health of patients, users or
third parties is not put at risk. This also applies to
medicaldevicesthataredisinfectedorsterilisedprior
tofirstuse.Properprocessingpursuanttosentence1
is assumed if the Joint Recommendation of the
Commission for Hospital Hygiene and the Prevention
of Infection at the Robert Koch Institute (RKI) and the
Federal Institute for Drugs and Medical Devices
(BfArM) on hygiene requirements when processing
medical devices has been observed.
3. The requirements pursuant to clause 1 are fulfilled
where the person commissioned to carry out the
maintenance on the basis of his/her training and
practicalworkhasthenecessaryspecialistknowledge
regarding the maintenance of medical devices, and
the premises necessary for this, including the condi-
tion,size,fixturesandfitting,aswellasthenecessary
equipment and other working materials, and is in the
position to carry out the processing properly and
verifiably in the required form and to the required ex-
tent.
4. Insofarasthesemayhavebeenaffectedbytherepair
measures,themainstructuralandfunctionalfeatures
essential to the safety and function must be tested
following maintenance or repair of medical devices.
The persons, businesses or institutions instructed to
carryoutthetestspursuanttoclause4mustfulfilthe
requirements pursuant to clause 3 and be independ-
ent in their expert judgement when carrying out and
evaluating the tests.
Thisregulationreferswithregardtotheproperprocessing
ofmedicaldevicestothejointRKIandBfArMrecommend-
ation. Thus, this recommendation is on a par with an ad-
vance expert opinion; it describes the “current technical
standard” and is thus de facto a German standard. Spe-
cialaccreditationruleswerecreatedwiththeirownsphere
ofapplicabilityforqualitymanagementsystemspursuant
to EN ISO 13485, in order to ensure evidence of the
conformityofmedicaldevicesprocessingwiththerequire-
ments of the relevant public. Here, the properties of the
medical device are assessed (outcome quality), as is the
procedurewithwhichtheproductwasproduced(process
quality).
For the sphere of applicability “processing medical
devices classified as ‘critical C’” there are currently four
accredited certifying bodies: DEKRA Certification GmbH
Stuttgart,LGAInterCertZertifizierungsgesellschaftmbH,
Nuremberg,MEDCERTZertifizierungs-undPrüfungsgesell-
schaftfürdieMedizinGmbHHamburgandTÜVRheinland
Product Safety GmbH Cologne.
Fororganisationsthatprovidemedicaldevices,irrespect-
ive of the type and size, the quality management norm
EN ISO 13485 “Medical devices – quality management
systems–requirementsforregulatorypurposes”applies.
Thisruledescribestherequirementsregardingthequality
of the structure and of the process. Due to safety consid-
erations, this norm was separated from ISO 9001 with
the2003issue.Themaindifferencesareinthefulfilment
of customer wishes, the regulatory requirements for
medical devices, and the exclusion of provisions of
ISO 9001, which are not suitable for medical devices.
Therequirementswithregardtooutcomequalityarealso
set forth in technical norms on medical devices, e.g. for
intravascular catheters, biocompatibility or specific pro-
cedures, such as cleaning, disinfection and sterilisation.
With regard to the processing of medical devices, the
joint RKI/BfArM recommendation also specifies the re-
quirementsforassuringtheoutcomequality.Forexample,
symbols for labelling medical devices are set out in DIN
EN 980. A large number of norms have been developed
for the biological assessment of medical devices; more
than 50 norms apply to sterilisation, cleaning and disin-
fection (see also Medical Standards Committee list of
norms on processing medical devices). These are by no
means exclusively device-related rules. Accordingly, EN
ISO14161undertheheading“Sterilizationofhealthcare
products – Biological indicators” sets out guidelines on
the selection, use and interpretation of results and EN
ISO14971appliestotheriskmanagementrequirements
for medical devices in the field of steam-sterilisation for
sterilised medical goods.
Inadditiontotheregulatoryandnormativerequirements,
the guidelines passed by consensus and expert recom-
mendations constitute the current accepted standard of
scientific knowledge. Although these are not legally
binding, in the event of a breach it must be proven in
what other way the necessary care was guaranteed. An
example of this is the final report of the RKI Task Force
vCJD:VariantCreuzfeldtJakobdisease(vCJD)–epidemi-
ology, detection, diagnosis and prevention, taking partic-
ular account of minimising risk of iatrogenic transfer
throughmedicaldevices,particularlysurgicalinstruments.
Process-oriented quality
management systems
By way of an example, this section will show, using the
quality management system of Vanguard AG, how a
quality management system certified pursuant to
ENISO13485,whichincludestheprocessingofcategory
“criticalC”medicaldevices,canbestructured.Inaccord-
ance with the joint opinion of the German Association for
Hospital Hygiene (Deutsche Gesellschaft für Kranken-
haushygiene, DGKH) and the Central Authority of the
Laender for Health Protection with regard to Medicinal
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for Gesundheitsschutz bei Arzneimitteln und Medizin-
produkten, ZLG) of August 2006, a certificate pursuant
to EN ISO 13485 must explicitly state that the require-
ments set forth in the joint RKI/BfArM recommendation
have been fulfilled if medical device processing with
particularly stringent requirements is carried out. Thus,
this description also applies to the area of central sterile
goods provision (Central Sterilisation Management De-
partment), as, in practice, the classification of medical
devices in categories “critical B” and “critical C” is often
unclear. While instruments such as laparoscopes, for in-
stance,aresterilisedusinggas(ethylene-oxideorformal-
dehyde) instead of with steam on account of the longer
useful life, these procedures usually fall within class
“critical C”.
The basis of a quality management system (QMS) is the
depiction of the business processes on a process map,
which is described in the quality management manual
(Figure 1).
The processes listed were structured and linked with
procedural instructions, taking into account the varying
degrees of complexity.
In order to keep the description brief but at the same
time provide an insight into the depth and the scope of
the work entailed in the development and maintenance
of a QMS, two management processes have been selec-
ted from the process map: the management process
“hygiene” and the area of risk management. These will
be described below. Furthermore, the following will be
presented in more detail: the core process ”processing
of medical devices with standardised, validated proced-
ures” and the core process “development of validated
procedures for medical device processing”.
Management process hygiene
Quality management in the field of hygiene can be
structured in different ways. The development of the hy-
giene plan was carried out on the basis of the rules and
regulations issued by the German Federation of Institu-
tions for Statutory Accident Insurance and Prevention
(Hauptverband der gewerblichen Berufsgenossenschaf-
ten, HVBG) “Biological substances in the healthcare sys-
tem and in social welfare” (BGR 250/TRBA 250). The in-
tegration of the hygiene plan was implemented in the
form of a procedural instruction in the quality manage-
ment documentation. Pursuant to Section 5.1.2 of the
Berufsgenossenschaften (BG) rules and regulations it is
possible to combine operating instructions and the hy-
giene plan. This option was selected for reasons of effi-
ciency.
The hygiene regulations were structured as follows:
Overview of the premises (description of the premises
and allocation of hygiene areas); personnel hygiene (list
of workwear and protective clothing); workplace hygiene
(furniture, equipment); premises hygiene (list of services
for commissioning external service providers); and the
cleaning and disinfection plan (measures, responsibilit-
ies). The monitoring and testing measures are lodged
next to the testing specifications in a hygiene register. In
this way, various specifications relating to water used in
processing, drinking water cold and warm, indoor air,
compressed air and the contamination of work surfaces
and personnel can be entered and recorded in the form
of a table.
So that the tasks and structures are obvious to each
employee,itisadvisabletodeveloppictogrammes,which
can be displayed at workstations, on devices and equip-
ment, as well as, if necessary, on the medical devices
themselves, or used in the documentation (Figure 2).
The use of pictogrammes increases the employees’ de-
greeofattentivenessandimprovesorientation.Although
graphic elements are used in BGR 250 in Annex 2 using
the example of an operating instruction, the rules and
regulations themselves do not contain any such require-
ments. Particularly in the case of persons with a non-
German-speakingbackgroundorwherethereischanging
personnelinaCentralSterilisationManagementDepart-
ment, it is very important that the visual communication
route is also used.
Core process and carrying out of
processing medical devices
The processing of medical devices is carried out exclus-
ively using standardised, validated procedures. Since in
the case of a “single-use product” responsibility is trans-
ferred to the processor, it must be confirmed that patient
safety is verifiably not put at risk by the processing and
that the function of the processed medical device is not
affected.
The core process passes through the following stages:
pre-fabrication;processing(cleaning/disinfection)includ-
ingtestingofsuccessofcleaningprocedureandfunction;
sterilepackaging;sterilisationandfinalpackaging(Figure
3).
Pre-fabrication: In this process stage, incoming control,
decontamination,identificationandclearlabellingofthe
medicaldevicesarecarriedout.Thepartialprocessstage
decontaminationincorporatestheacceptanceofacollec-
tion box from the goods entrance and disinfectant pre-
cleaning of the medical devices contained therein. Pre-
cleaning serves first and foremost personnel protection.
Medical devices for which processing can be excluded
on the basis of the incoming control (e.g. initial contam-
ination, medical devices incomplete, mechanical dam-
age), are not passed on to the decontamination process,
but rather are barred immediately and disposed of as
category B waste. The customers are informed as to the
medicaldevicesreceivedwiththecorrespondingproduct
status in the form of a confirmation of goods received.
Processing:Thisprocessstageencompassesthecomple-
tionofthepreparatorystagesdefinedforprocessing(e.g.
disassembly, assembly, cleaning, disinfection steps) and
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testing steps (e.g. 100% product tests, batch testing,
functional tests).
Sterile packaging: This process stage consists of the
visual check, final disinfection, protective packaging by
machine, sterile packaging, sealing and checking of the
sealed sterile packaging.
Sterilisation: Sterilisation encompasses the allocation of
the sterile packaged medical devices to a sterilisation
process pursuant to the working plan, as well as carrying
out the sterilisation in accordance with the required
testingandreleasemeasures,suchas,e.g.batchtesting
and visual product control.
Final packaging: In this stage of the process the medical
devices are packed into article-specific external pack-
aging, the labels are produced and affixed. Following a
finalcheck,themedicaldevicesarereleasedfordistribu-
tion. The products are sorted according to customer
specifications,packedintoindispatchboxesandhanded
over to the shipping company.
If individual medical devices are excluded from pro-
cessing, this is done stating a specified reason for exclu-
sion selected from a catalogue of reasons. However,
products are not excluded solely at the pre-fabrication
stage, but rather at various points in the process chain.
In addition to the purely technical view of the process,
the selection of the medical device and the expected
success of the processing for a medical device supplied
by the customer, i.e. the sustainability of the service
model, are worthy of particular attention. The DGKH and
the ZLG correctly state in their joint opinion “Ethical, hy-
gienic and legal aspects of the processing of medical
devices”, that “the processing, irrespective of whether
themedicaldeviceisdeclaredforsingleorrepeateduse,
is even more worthwhile the greater the material and re-
sources needed to manufacture the medical device in
question is” and, further, “In the case of disposable
medical devices such as e.g. hypodermic syringes, the
volume of materials used to manufacture the product is
bynomeansinareasonablerelationshiptotheresources
used and hygiene safety in processing, so that this med-
ical device is to be disposed of following a single use”.
This clarifies the economic and ecological dimension of
processing. However, one must also take into account
the aspect of the “willingness” of the customer and,
specifically,thephysicianusingtheproduct,toreprocess
medical devices.
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Learning curve
The objective of pre-fabrication (incoming control) is to
excludefromfurtherprocessingmedicaldevicesthatare
damaged, incomplete, seriously contaminated or which
have not been roughly cleaned in the form agreed with
the customer. Yet one and the same medical device e.g.
a scraper used in a knee joint arthroscopy can in the
course of one use, be used differently from case to case
andinparticularwithvaryingdegreesofintensity.Accord-
ingly, any expectations of a specific quota of processing
and thus re-use of the medical devices must be rejected
from the outset. It has, however, become apparent that
with increasing experience and knowledge of processing
technologies on the part of all involved, the degree of
processing can be increased – sometimes drastically.
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Thus, for instance, broken connections in Luer locks can
now for the most part be avoided. The successes that
can be achieved using the example of the EP diagnostic
catheter can be seen clearly in Figure 4. But here also,
as is generally known in the quality management field,
only a constant drip can hollow stone. Programmes to
improve quality, once begun, from time to time need a
re-launch.Bonuspaymentslinkedwitheconomicsuccess
are made transparent for all those involved by providing
such evaluations, and the quality of the processing suc-
cess is experienced first hand. Broad acceptance of
economicthinkingandactionsinmedicineisencouraged
by a quality management system that is targeted at fig-
ures, data, and facts and is, thus, transparent.
Core process "Development of
validated procedures"
For the development of procedures for processing med-
ical devices, as a central component of Vanguard AG’s
special processing a service model was created. It in-
cludes: the customer inquiry, an estimate of the need for
development, a feasibility study and an estimate of the
cost. If the development is approved, the design and de-
velopment planning procedure follows the same course
asforamarketauthorisationofthemedicaldevices.The
special feature of this development process is the
product-specific view. If a medical device is sent in and
there is already a validated procedure for the group of
articles to which the device belongs, the product-specific
peculiaritiesareconsideredand,accordingly,itisdecided
whichtestsarenecessaryinordertoprocessthemedical
device.Onlyfollowingsuccessfulcompletionofallofthese
tests is the processing of the medical devices approved
(Figure 5).
Thecoreprocessofdevelopmentofvalidatedprocedures
was structured as follows:
• preliminary tests
• design and development specifications (design input)
• design output
• transfer to production (design transfer)
• changes to medical devices (change management)
• risk analysis and management
Risk analysis and risk management constitute a cross-
divisionalfunctionandaccompanytheentiredevelopment
process.Theinformationnecessaryforriskmanagement
is derived from all phases of the core process. The risk
parameters also serve the direct control of the further
procedure in each individual phase. For this reason, the
aspectsofoverridingimportance,andtheeffectsthereof
on change management are highlighted in the section
on risk management, below.
Preliminary tests: The main quantitative and qualitative
features are identified and the cost-effectiveness is
evaluated using manufacturer information, information
from literature, norms and experience. The following
factors are identified: method of sterilisation, whether
7/15 GMS Krankenhaushygiene Interdisziplinär 2008, Vol. 3(3), ISSN 1863-5245
Klosz: Quality management for the processing of medical devices...Figure 5: Schedule of the development process
the devices can be rinsed as well as special features in
the material and the construction, such as e.g. whether
the device can be dismantled. The result of the prelimin-
ary tests is the decision on whether, in principle, the
devices can be reprocessed.
Design and development specifications (design input):
The design and development specifications are defined
indetailandaprojectplanisprepared.Therequirements
arederivedfromthecorrespondingnormsanddirectives.
These result in a list of the individual product specifica-
tions,suchas,forexample,permissiblelengthordiamet-
ertolerance,ascertainingthetensilestrength,ascertain-
ing electric characteristic values, such as e.g. insulation
resistance, line resistance. In this way, the specifications
for each individual medical device are drawn up. These
specifications are then tested in the course of the valida-
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time, these specifications represent limit values. If these
values are exceeded, the medical device is barred. The
specifications are clearly formulated.
The functional parameters are supplemented by require-
ments in terms of cleanliness, hygiene, sterility and pos-
sible sterilisation residue, including endotoxic contamin-
ation. These parameters are the same for all medical
devices and are set forth in the validation standard
“Processing medical devices – general requirements”.
Furthermore, requirements in the individual procedures
are defined, e.g. rinsing devices, requirement of special
rinsingadapter,andexclusionofcertainparameterssuch
as temperature, use of certain chemicals.
Aprojectplanisdrawnupwhichunderpinsthenecessary
development work with resources and deadlines. The
result of this development phase (“Design Input” phase)
are defined requirements for the medical devices (limit
values) for the processing procedure, in the form of a
target specification or a validation standard, the first
stage of a risk management plan and a project plan. The
packaging requirements are also specified in this phase.
Design output: This is where the actual design activit-
ies/verificationarecarriedout,theriskmanagementplan
is developed further and the validation is planned and
implemented.
These activities also lead to the development of the ne-
cessaryfunction-testingdevicesforthearticlegroup.The
required packaging materials (e.g. machine protective
packaging, protective caps) are defined and a label tem-
plateisprepared.Itisatthisstagealsothattheappropri-
ate machines are selected, together with the parameter
set and the agents. This constitutes the actual testing
phase.
Theriskmanagementplanissupplementedwithproduct-
specific specialities. In this way, critical constructional
elements, such as the various anti-kink devices for PTCA
catheters or various forms of handle for ablation cathet-
ers, are determined and their risk potential with regard
to the processing is assessed. Furthermore, the critical
process stages are determined. This is based on the
philosophythateachprocessstageduringtheprocessing
(cleaning, disinfection, sterilisation, testing, storage) can
affect the medical devices. In order better to be able to
assess the risk, tests are included in the validation on
the basis of this risk evaluation, which allow the effect of
repeated use of the medical devices to be evaluated.
In parallel, in the course of the validation planning a list
is drawn up of the tests that are necessary in order veri-
fiably to fulfil the requirements set out in the preceding
development phase, and to limit or exclude the ascer-
tained risks. In addition to tests on the hygienic safety,
the validation plan includes tests on functional paramet-
ers and safety-relevant tests. At this point, the long-term
tests that are necessary in order to be able to repeatedly
process medical devices are also planned.
Prerequisites for the selection of
medical devices
A quality management system that sets out and docu-
ments all stages is required for the processing. DGKH
andZLGdemandthattheeffectivenessoftheprocedures
be underpinned by product or product-group specific
tests,whichmustbeprecededbyvalidationinaccordance
with the current standard of technology. Any negative ef-
fects of the processing on the material properties and
thetechnical-functionalsafetymustbeexcludedthrough
adequate testing procedures. For disposable products,
for which reprocessing is to be considered, the demand
for “labelling” arises. In the special processing carried
out by Vanguard AG, only medical devices that can be
clearly labelled (serial number) by way of laser engraving
are included in the preliminary selection. If there is no
placee.g.onahandleoranadapter,thatcanbeindelibly
marked without causing damage, then processing is
prohibited, even if it would otherwise be possible. If we
have products from one and the same class with the
same function e.g. the arthroscopic scraper of manufac-
turers A and B, the task is to ascertain which product is
suitable for labelling. For decisions regarding repeat or-
dersthisisanimportantcontributionmadebythespecial
processor for his partner in the healthcare system, the
clinical purchasing department. Once the products have
beenidentified,thedevelopmentofaprocessingproced-
ure begins. At first glance, it is easy if the manufacturer
sellsthemedicaldeviceasre-usableandsuppliesinstruc-
tions for use. Here, “instructions for use” is often the
more accurate description since this document is some-
times so brief that it cannot actually be referred to as a
“processing guideline”. The processor must also exclude
incorrect interpretations that can result, for example,
frominaccuratetranslations.Thetemperatureinformation
and the recommended duration of sterilisation usually
dependonthetechnologyandchemicalsused.Manufac-
turers very often provide only general information. The
following is an excerpt from instructions for use for arth-
roscopic scrapers designed for a limited number of re-
uses made by a well-known manufacturer: “After rinsing,
immerse all cutting instruments in a cleansing solution
with a neutral pH-value, in order to remove or loosen
blood,tissueandsebum”.Thisdoesnotcorrespondwith
the state of the art, pursuant to which, for reasons of ef-
fectiveness (e.g. to combat TSE virus) alkaline solutions
arepreferable.Informationprovidedbythemanufacturer
regarding manual cleaning of their medical devices fails
to fully reflect the practical realities. Thus, the following
cleaning instruction, which again originates from a
renowned manufacturer of arthroscopic scrapers, must
be implemented by the processor in a corresponding
programme with defined machine cycles and testing cri-
teria: “Do not use scourers or steel wool to clean the in-
struments.Removestubborndirtwithasurgicalscrubbing
brush,bybrushingthroughtheinternalcuttingbladeand
the outer shell from inside. After soaking and prior to
9/15 GMS Krankenhaushygiene Interdisziplinär 2008, Vol. 3(3), ISSN 1863-5245
Klosz: Quality management for the processing of medical devices...sterilisation, rinse the instruments under running water
for at least three minutes, until the water runs clear”.
Here,aprocessorisrequiredtocarryoutextensivefollow-
up measures and adjustments in order to bridge these
gaps. He must therefore “develop” in order to achieve a
procedure that corresponds with the current state of the
art – to use the language of the norms, he must ensure
“processing according to a controlled and validated pro-
cess”.
AtVanguard,asaresultoftheriskmanagementprocess,
a special approach was determined for dealing with
medicaldevicesthatareregularlyusedinTSErisktissue.
In addition to two processing stages recommended by
the RKI for these purposes (e.g. high-alkaline cleaning),
these products are also subject to a protein residue test
in parallel to the process. This raised the safety of the
processing to a higher level, which was secured further
by way of the test.
Ariskassessmentofthiskindwiththeresultantmeasures
should, however, already have been carried out by the
manufacturerofamedicaldeviceintendedtobere-used,
since the risk of transfer of TSE virus arises solely on ac-
count of the intended use. There is thus no increased
risk for products marked as single-use only; on the con-
trary,theriskofcontaminationwithprionsforallmedical
devices used in TSE-risk tissue must be dealt with.
Once a medical device has attained the status “author-
ised for processing”, Vanguard AG records the stages of
theprocedureinanIT-basedtrackingsystem.Ifacustom-
er provides a medical device for processing, the medical
devices supplied are directed into one of two core pro-
cesses; in the case of first processing this occurs after
the productshave been identified by way of laserengrav-
ing (Figure 6).
Figure 6: Identification procedure
The medical devices with the status “authorised for pro-
cessing” represent the entire spectrum of processable
products. The medical devices with the status “in devel-
opment” reflect potential future activities. The classifica-
tion “not processable” means that, according to the
evaluation, no processing procedure is available for the
medical device.
The cleaning effectiveness is directly linked to the geo-
metry and type of contamination of the specific medical
devices. The following two situations may arise:
• Thereisnosuitablefacility,nosuitablerinsingadapter
ornocleaningprocedure(cleaningproductsanddisin-
fectants, temperature, number of cleaning and rinse
cycles). With the development of facilities, rinsing ad-
apters or procedures, first of all, tests are carried out
to determine whether all component parts of the
medical devices can be sufficiently rinsed. To begin
with, coloured soiling agent is used. Only after the
parameters have been successfully ascertained
(pressure, temperature, number of cycles etc.), is test
soilingcarriedout.Thecleaningeffectivesisassessed
visually, by ascertaining residue containing protein
(OPA), by ascertaining microbial contamination
(bioburden test) after cleaning and by determining
bacterial endotoxins after cleaning and sterilisation.
If necessary, tests for residue tensides or degradation
products of the substances used are also carried out.
Spectroscopic or titrimetric methods are used here.
Only once the cleaning effectiveness is successful in
all points can the procedure be approved for pro-
cessing.
• Ifanewmedicaldevicecanbeprocessedinanexisting
facilitywithknownrinsingadaptersandknownproced-
ures (cleaning and disinfectant agent, temperature
range, etc.), the cleaning effectiveness is measured
by cleaning a representative selection of applied
medical devices using the existing procedures. Here,
too, the procedure is approved only once all aspects
of the process have been verified as safe.
Theresultofthe“DesignOutput”phaseissuitabletesting
apparatus,allocatedpackagingandidentificationmeans,
designated machinery and parameter rates, the second
step of a risk management plan and a validation plan.
Transfer to production (design transfer): During the con-
cludingDesignTransfer-Phaseinthecourseoftheimple-
mentationofproductionthedevelopedtestingapparatus
and any necessary raw materials are handed over and
the production staff is provided with training on how to
operate the machinery and the testing apparatus.
Astudyprotocolisdevelopedwhichsetsoutwhatproduct-
specific tests have to be carried out in parallel to the
production, for which medical devices, and with which
specifications to what extent and at which control point.
Since many tests are damaging, the procedures are de-
veloped so that a parametric assessment can be made.
Inthisway,usingtheevaluationoftherecordedmachine
parameters, the processed batch can be released. In
addition, the use of test blocks and the examination of
process media are planned. The study protocol is integ-
rated into the working plan.
The design transfer concludes the validation. Using the
results from the validation tests, all requirements for the
medical device and the procedure are confirmed and it
is determined for each medical device, how often, in
theory, it can be processed. New products are also used
for the validation.
The result of this phase is a validated procedure for
defined medical devices in a product group. This is ex-
pressedinanapprovedworking-plansheet,whichmakes
reference to the necessary documents (manufacturing
and testing instructions, operating instructions, etc.)
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As explained in the context of the development of valid-
ated procedures, the process of developing procedures
andproductreleaseisaccompaniedbyriskmanagement,
taking into account the special features of the re-use of
the medical device. On the basis of the classification
pursuant to the “hygiene requirements when processing
medical devices”, the hygiene risks that result from con-
taminationwhenusedasinstructedareassessed.Already
atthepreliminaryplanningstage,(Design-Input)mechan-
icalstrainduringuse,theeffectofstorage/transport,the
strain on the medical devices caused by the individual
processing stages, including the necessary tests for the
article group, are monitored. The procedure follows
EN ISO 14971, which concerns the application of risk
managementtomedicaldevices.Thenormassumesthat,
whenusingamedicaldevice,ariskhastwocomponents.
These are, firstly, the likelihood of the occurrence of
damage and secondly, the results or the severity of this
damage.Thenormisaddressedprimarilytothemanufac-
turers of medical devices, but also identifies physicians,
patients, the government and the public as involved
parties.Thenormalsoseesitselfasanintermediary:“All
thoseinvolvedmustunderstandthattheuseofamedical
device involves a certain degree of risk” and further “the
perception of the risk on the part of those involved can
vary greatly, depending on the type, including cultural
background, the socio-economic background and the
level of education of the relevant society, of the actual
and perceived health of the patient and many other
factors”. The norm applies for the entire lifecycle of a
medical device. Thus, the risk management process en-
compasses not only the risk assessment prior to placing
on the market, but also risk monitoring on completion of
theproduct.Thedocumentationiscarriedoutintheform
of a risk management file (Table 1). This file serves to
prove the “completeness of the risk management”. This
includes the evaluation of existing and recognised risks,
the development of measures to minimise risks and the
re-evaluation thereof, in order, in this way, to verify the
management of the remaining risks. The norm does not,
however, set out any acceptable levels of risk. This re-
mains the decision of the manufacturer or the groups
involved. Nevertheless, Annex D to the norm (risk con-
cepts)containssuggestionsforqualitativeandquantitat-
ive analyses. In practice, this results in a risk chart, in
which an acceptance parameter is formed from the risk
potential, the identifiability and the likelihood of occur-
rence.
The specific use will now be clarified using the example
of a risk analysis for an arthroscopic scraper (Table 2).
Two functions of the analysis were selected: 'the removal
of tissue (cutting) – subpoint 2.3. “unclean removal”’
and, as a contribution to the issue of reprocessing, ‘pro-
cessing – subpoint 7.4. “introduction of foreign material
or processing means to the organism”’.
In both cases, it is possible using appropriate measures
to reduce the risk from level 9 (unacceptable) to risk
level 6 (“as low as reasonably practicable”; ALARP). In
the course of the further development of the norm
ISO14971:2005,theriskclasseswereconsolidatedinto
just two groups – acceptable risk and unacceptable risk.
The manufacturer and the user are, however, free to
employ individual risk management techniques. Accord-
ingly, Annex G to the norm lists the following techniques
as suitable and useful:
• Preliminary Hazard Analysis (PHA) – a technique that
can be used at an early stage of the development of
a medical device.
• Fault Tree Analysis (FTA) – helpful when interpreting
safetytechnologyanddeterminingrankingofhazards.
• Failure Mode and Effect Analysis (FMEA) – to support
riskassessmentsandriskmeasuresoncethemedical
devices is completed.
• HazardandOperabilityStudies(HAZOP)andthehazard
analysesandcriticalcontrolpoints(HACCP)arerecom-
mended for the verification and optimisation of struc-
ture designs. HAZOP is similar to FMEA. HACCP was
developed by NASA in order to prevent food poisoning
among astronauts. In the area of medical devices it
helps in the cause analysis for hazards.
Thus, there are a series of accepted methods for man-
aging risk. The structure of the risk management file
should reflect the fact that risk management is continu-
ously developing further.
Particular aspects of special
processing
Whenprocessingmedicaldevicesreleasedbythemanu-
facturer for single use, an essential aspect of the risk
considerations is recognising critical areas, which, in the
event of modifications, can affect functional or hygiene
properties of the product, such as e.g. anti-kink variants,
shape of handles.
As modifications can also affect the labelling, medical
devicesshouldonlybeprocessedifthecustomeratleast
provides the manufacturers’ labels for each individual
medical device. Since the release for processing must
relate to a specific article, any change to the manufac-
turer’s reference (catalogue number) is immediately ap-
parent and has to be reprocessed by the development
department. Changes to the contents or the design of
the label will also be obvious to trained finishing staff. In
such cases the relevant responsible person is to be in-
formed, and will then decide on how to proceed.
Changes or modifications are occasionally made by the
manufacturerunderthesamereferencenumber.Atypical
example of a modification is alterations to join connec-
tions, which can be mechanical (screw, snap-in) or
chemical (glue, welding). For this reason, tests to accom-
pany the production stage are derived from the risk ana-
lysis.
Possible changes to the materials that are not stated in
the manufacturer’s documentation are highly unlikely,
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Table 2: Risk analysis for an arthroscopic scraper (excerpts)
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changes, if necessary biocompatibility certificates, proof
of function) is used as a marketing instrument of “tech-
nical innovation”. For medical devices with a relatively
short life-span, such as PTCA catheters, changes of this
kind(e.g.changeincolour)accountforalargeproportion
of competition. This is why revalidations are planned and
carried out for instruments with a long useful life.
Recognised modifications or high error rates lead to a
modification in the risk assessment and changes to the
test frequency and level of the tests. For this reason, in
practice, it is not uncommon for a medical device to be
unsuitable for reprocessing following modification.
Changes to medical devices
(Change management)
When developing validated procedures for processing
medicaldevicesitisparticularlyimportantthatmodifica-
tions by the manufacturer are taken into account
throughout the entire life-cycle of the medical device.
UndertheprovisionsoftheMedicalDeviceAct,alterations
to medical devices by the manufacturer are subject to a
documentation obligation and, depending on the classi-
fication of the medical device, have to be notified to the
designated authorising body. There is not, however, an
obligationtonotifychangestotheuserand/orprocessor.
This relates to both single-use products and medical
devices declared to be for repeated use.
Consequently, to ensure patient safety within the frame-
work of quality management, a change management
systemmustbeinstalledinthefunctionalareasofdevel-
opment, production and distribution. It includes risk
analyses,releasedecisions(validation),continualmonit-
oring in the form of tests accompanying the process,
market observation and revalidation. Regular product-
specific training and a close communicative connection
between the individual areas of operation are additional
cornerstones of change management.
The use of process software and the individual labelling
of each individual product ensures that it is possible at
all times to react to alterations to medical devices by
barring them from processing or, if necessary, carrying
outatargetedproductrecall.Theseinstrumentscanalso
be used to react to product recall measures by the man-
ufacturers of medical devices.
The development of risk management systems and the
partial components thereof, such as Change Manage-
ment, is a necessity arising both from ISO 14971 and the
Medical Devices Operator Ordinance, which has already
beenpresentedindetail.Section4MPBetreibVsetsforth
thelegalrequirementswhenprocessingmedicaldevices.
Qualified staff, expert knowledge and technical facilities
suitable to meet the requirements form the basis of an
effectiveriskmanagementsystem.Aqualitymanagement
system pursuant to EN ISO 13485 forms the keystone
for the sustainable, cost-effective and efficient provision
of services in the sterile goods supply sector.
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